Clinical and Laboratory Findings on the First Imported Case of Murray Valley Encephalitis in Europe
Open Access
- 15 July 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (2) , e19-e21
- https://doi.org/10.1086/375068
Abstract
Murray Valley encephalitis (MVE) is an important mosquitoborne flavivirus infection endemic to Australia and Papua New Guinea. We report the first imported case of MVE in Europe. A 23-year-old tourist developed severe encephalitis after having returned to Germany from a long-term trip across the Australian continent. The diagnosis was suspected on the basis of clinical findings and the patient's travel history and was confirmed by serological findings. The patient made a prolonged but complete recovery. Our case coincides with a recently reported spread of MVE virus in Australia. This emphasizes the need for continuous surveillance in areas of endemicity and appropriate protection when traveling through regions in which the MVE virus is endemic.Keywords
This publication has 5 references indexed in Scilit:
- Dengue and Other Emerging FlavivirusesJournal of Infection, 2001
- Arboviruses associated with human diseasein AustraliaMicrobes and Infection, 2000
- Ribavirin Inhibits West Nile Virus Replication and Cytopathic Effect in Neural CellsThe Journal of Infectious Diseases, 2000
- Australian encephalitis in the Northern Territory: clinical and epidemiological features, 1987–1996Australian and New Zealand Journal of Medicine, 1998
- Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infectionAntimicrobial Agents and Chemotherapy, 1993